BURKHOLDERIA PSEUDOMALLEI OSTEOMYELITIS

Jane Li(Cell Technology (China)), Hilton Gock(St Vincent's Hospital Melbourne), Amy Crowe(St Vincent's Hospital Melbourne), John Daffy(St Vincent's Hospital Melbourne)
Australasian Medical Journal
January 1, 2012
10.21767/amj.2012.1025
Cited by 0

Related Papers

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance
|JAMA|2018|779
Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation
|Journal of Clinical Investigation|2004|183
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study
|Clinical Infectious Diseases|2020|159
Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27
|Journal of Antimicrobial Chemotherapy|2017|85
Predicting functional capacity during treadmill testing independent of exercise protocol
|Medicine & Science in Sports & Exercise|1996|74